Cargando…

Primary Central Nervous System Lymphoma With Systemic Recurrence

Primary central nervous system lymphoma (PCNSL) is an extranodal non-Hodgkin’s lymphoma confined to the brain, leptomeninges, spinal cord, or eyes without systemic involvement. Nearly half of patients with PCNSL who achieve complete remission, relapse within five years. The majority of patients who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandravada, Sasirekha, Knouse, Phillip, Bitran, Jacob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555944/ https://www.ncbi.nlm.nih.gov/pubmed/34729283 http://dx.doi.org/10.7759/cureus.18406

Ejemplares similares

DA-REPOCH Versus R-CHOP for the Treatment of Activated B-Cell Subtype Diffuse Large B-Cell Lymphoma: A Community Center Experience
por: Knouse, Phillip, et al.
Publicado: (2020)

The Role of Navitoclax in Myelofibrosis
por: Pandravada, Sasirekha, et al.
Publicado: (2021)

Stereotactic Radiotherapy for Recurrent Post-Transplant Primary Central Nervous System Lymphoma
por: Benitez, Cecil M, et al.
Publicado: (2021)

Relapsed Primary Central Nervous System Lymphoma: Current Advances
por: Tao, Kaiyan, et al.
Publicado: (2021)

Editorial: Advances in the treatment of primary central nervous system lymphoma
por: Qian, Liren, et al.
Publicado: (2023)

Stereotactic Radiosurgery for Primary Central Nervous System Lymphoma
por: Wu, Susan Y, et al.
Publicado: (2023)

Socioeconomic deprivation and survival outcomes in primary central nervous system lymphomas
por: Deng, Xiangyang, et al.
Publicado: (2022)

Recent Progress on Primary Central Nervous System Lymphoma—From Bench to Bedside
por: Shao, Liang, et al.
Publicado: (2021)

The Role of BAFF-R Signaling in the Growth of Primary Central Nervous System Lymphoma
por: Zhou, Xiaolan, et al.
Publicado: (2020)

Real-World Impact of Surgical Excision on Overall Survival in Primary Central Nervous System Lymphoma
por: Deng, Xiangyang, et al.
Publicado: (2020)

The Role of Rituximab in Primary Central Nervous System Lymphoma
por: Bromberg, Jacoline E. C., et al.
Publicado: (2020)

Local Control of Primary Dural Central Nervous System Lymphoma Achieved With Radiotherapy
por: Vallejo, Alexandra, et al.
Publicado: (2021)

Primary Central Nervous System Lymphoma  with Peripheral Nerve Involvement:  Case Report
por: Mori, Yoshimasa, et al.
Publicado: (2019)

Complete Blood Count Score Model Predicts Inferior Prognosis in Primary Central Nervous System Lymphoma
por: Feng, Yuhua, et al.
Publicado: (2021)

Analysis of Cellular Heterogeneity in Immune Microenvironment of Primary Central Nervous System Lymphoma by Single-Cell Sequencing
por: Wei, Boyuan, et al.
Publicado: (2021)

Bruton’s tyrosine kinase inhibitors in the treatment of primary central nervous system lymphoma: A mini-review
por: Shen, Jing, et al.
Publicado: (2022)

Recent Advances in Treatment of Primary Central Nervous System Lymphoma
por: Nayak, Lakshmi, et al.
Publicado: (2013)

Primary Central Nervous System Lymphoma
por: Dong, Yan-Hong, et al.
Publicado: (2016)

Primary central nervous system lymphoma
por: Gloghini, Annunziata, et al.
Publicado: (2015)

Primary central nervous system lymphoma
por: Löw, Sarah, et al.
Publicado: (2018)

MicroRNAs as Diagnostic Biomarkers in Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis
por: Zheng, Xiaohong, et al.
Publicado: (2021)

Comparison of Radiomics-Based Machine-Learning Classifiers in Diagnosis of Glioblastoma From Primary Central Nervous System Lymphoma
por: Chen, Chaoyue, et al.
Publicado: (2020)

mTORC1 signaling in primary central nervous system lymphoma
por: Nitta, Naoki, et al.
Publicado: (2016)

Rare Primary Central Nervous System Tumors in Adults: An Overview
por: Franceschi, Enrico, et al.
Publicado: (2020)

Partial-brain radiotherapy for primary central nervous system lymphoma: multi-institutional experience
por: Iwabuchi, Michio, et al.
Publicado: (2016)

The Efficacy and Safety of Cytarabine on Newly Diagnosed Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis
por: Zheng, Xiaohong, et al.
Publicado: (2020)

Epidemiologic Characteristics, Prognostic Factors, and Treatment Outcomes in Primary Central Nervous System Lymphoma: A SEER-Based Study
por: Tang, Dongsheng, et al.
Publicado: (2022)

Non-cancer-specific survival in patients with primary central nervous system lymphoma: A multi-center cohort study
por: Chi, Kaiyi, et al.
Publicado: (2023)

Radiotherapy or chemotherapy: a real-world study of the first-time relapsed and refractory primary central nervous system lymphoma
por: Yang, Yu, et al.
Publicado: (2023)

Local recurrence of primary central nervous system lymphoma due to tumor seeding
por: Madkhali, Ibrahim, et al.
Publicado: (2013)

Primary intercavernous lymphoma of the central nervous system
por: Dultra, Arthur Henrique de Aquino, et al.
Publicado: (2015)

Immunotherapy associated central nervous system complications in primary brain tumors
por: Mantica, Megan, et al.
Publicado: (2023)

Prognostic Role of Blood Markers in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate-Based Therapy
por: Luo, Qian, et al.
Publicado: (2021)

Cardiovascular Death Risk in Primary Central Nervous System Lymphoma Patients Treated With Chemotherapy: A Registry-Based Cohort Study
por: Guan, Tianwang, et al.
Publicado: (2021)

Primary Central Nervous System Lymphoma (PCNSL): Analysis of Treatment by Gamma Knife Radiosurgery and Chemotherapy in a Prospective, Observational Study
por: Alvarez-Pinzon, Andres M, et al.
Publicado: (2016)

Orelabrutinib Combined With Lenalidomide and Immunochemotherapy for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Retrospective Analysis of Case Series
por: Yang, Chuanwei, et al.
Publicado: (2022)

Peripheral T-Cell Lymphomas Involving the Central Nervous System: A Report From the Czech Lymphoma Study Group Registry
por: Mocikova, Heidi, et al.
Publicado: (2022)

Combination Therapy with Rituximab and Temozolomide for Recurrent and Refractory Primary Central Nervous System Lymphoma
por: Murakami, Mineko, et al.
Publicado: (2011)

Efficacy of Procarbazine, Lomustine, and Vincristine Chemotherapy for Recurrent Primary Central Nervous System Lymphomas
por: Kim, Young-Joo, et al.
Publicado: (2015)

Cardiovascular Outcomes in the Patients With Primary Central Nervous System Lymphoma: A Multi-Registry Based Cohort Study of 4,038 Cases
por: Qiu, Zicong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q2po0fhs5u866jg0rsii3q0eal